HALÁMKOVÁ, Jana, Zbyněk ČECH, Zdeněk PAVLOVSKÝ, Jiří TOMÁŠEK, Štěpán TUČEK, Adam SVOBODNÍK, Lada HANÁKOVÁ, Mojmír MOULIS, Igor KISS and Miroslav PENKA. Significance of plasminogen activator inhibitor type 1 and its gene polymorphism in colorectal carcinoma patients. In XIXth International congress on fibrinolysis and proteolysis. Vienna, Austria, 2008, p. 142-142, 180 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Significance of plasminogen activator inhibitor type 1 and its gene polymorphism in colorectal carcinoma patients
Name in Czech Význam plazminogen aktivátor inhibitoru typ 1 a jeho genetického polymorfismu u pacientů s kolorektálním karcinomem
Name (in English) Significance of plasminogen activator inhibitor type 1 and its gene polymorphism in colorectal carcinoma patients
Authors HALÁMKOVÁ, Jana, Zbyněk ČECH, Zdeněk PAVLOVSKÝ, Jiří TOMÁŠEK, Štěpán TUČEK, Adam SVOBODNÍK, Lada HANÁKOVÁ, Mojmír MOULIS, Igor KISS and Miroslav PENKA.
Edition Vienna, Austria, XIXth International congress on fibrinolysis and proteolysis, p. 142-142, 180 pp. 2008.
Other information
Type of outcome Proceedings paper
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English PAI 1, gene polymorphism, colorectal cancer
Tags International impact
Changed by Changed by: MUDr. Jana Halámková, Ph.D., učo 19117. Changed: 30/10/2008 20:31.
PrintDisplayed: 28/7/2024 10:25